leadf
logo-loader
LSE:NFX FRA:1RT

Nuformix PLC

Receive alerts
Market:
LSE
Market Cap:
£7.81 m
Price
1.32 GBX
Change
-2.22%
52 weeks high
4.48
52 weeks low
1.25

In brief

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing.

The Company aims to use its expertise in discovering, developing and patenting novel drug forms, with improved physical properties, to develop new products in new indications that are, importantly, differentiated from the original (by way of dosage, delivery route or presentation), thus creating new and attractive commercial opportunities. Nuformix has an early-stage pipeline of preclinical and Phase 1-ready assets with potential for significant value and early licensing opportunities.

Snapshot

By developing new forms of safe drugs, the company generates its own intellectual property and may shorten the timeline to market